SCHEMBL2474515

SCHEMBL2474515

c1nc2cc(-c3ccc4nc[nH]c4c3)ccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ QPCT Q16769 6/20 0.60
▸ QPCTL Q9NXS2 4/20 0.60
▸ PRKCI P41743 2/20 0.55
▸ KDM4E B2RXH2 4/20 0.53
▸ MAPT P10636 3/20 0.53
▸ RAD52 P43351 1/20 0.53
▸ BRD4 O60885 1/20 0.51
▸ CREBBP Q92793 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ TP53 P04637 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MMP12 P39900 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ CYP3A4 P08684 1/20 0.49
▸ NAMPT P43490 1/20 0.49
▸ XDH P47989 1/20 0.49
▸ APEX1 P27695 1/20 0.48
▸ RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8634290 0.92 QPCT (0.68) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL31143361 0.92 MAPT (0.50) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL6008269 0.92 MAPT (0.50) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL2462345 0.82 QPCT (0.68) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL2457365 0.82 QPCT (0.50) QPCTQPCTLKDM4EMAPTALDH1A1
SCHEMBL17283574 0.82 QPCT (0.51) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL13373486 0.81 PARP1 (0.46) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL7021134 0.81 QPCT (0.49) QPCTQPCTLKDM4EMAPTALDH1A1
SCHEMBL38665709 0.81 QPCT (0.66) QPCTQPCTLPRKCIKDM4EMAPT
SCHEMBL7021141 0.81 QPCT (0.66) QPCTQPCTLPRKCIKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2907813-B1 Antibacterial pharmaceutical compositions SUMMIT THERAPEUTICS PLC (GB) 2016-04-27 — — EP claimed
US-9314456-B2 Antibacterial compounds SUMMIT THERAPEUTICS PLC (GB) 2016-04-19 — — US claimed
EP-3095783-A1 ANTIBACTERIAL COMPOUNDS Summit Corporation Plc (GB) 2016-11-23 — — EP disclosed
EP-3011960-A1 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE Summit Therapeutics plc (GB) 2016-04-27 — — EP disclosed
WO-2011151620-A1 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE SUMMIT CORPORATION PLC (GB) 2011-12-08 — — WO disclosed
WO-2011151618-A2 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE SUMMIT CORPORATION PLC (GB) 2011-12-08 — — WO disclosed
EP-2373631-A2 ANTIBACTERIAL COMPOUNDS Summit Corporation Plc (GB) 2011-10-12 — — EP disclosed
WO-2010063996-A2 ANTIBACTERIAL COMPOUNDS SUMMIT CORPORATION PLC (GB) 2010-06-10 — — WO disclosed
Send feedback